Involvement of increased arginase-1<sup><b>+</b></sup> group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma: A pilot study.

J Int Med Res · 2026 · PMC13047281 · PMID 41912235

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

did not reach statistical significancep = 0.056so close (0.05 < p ≤ 0.1)

Although the ratio of Arg-1 + ILC2s/ILCs in PBMCs was higher in patients with EC than in controls, this difference did not reach statistical significance (p = 0.056, Figure 2(e) ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Involvement of increased arginase-1&lt;sup&gt;&lt;b&gt;+&lt;/b&gt;&lt;/sup&gt; group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma: A pilot study.

The sentences

Involvement of increased arginase-1<sup><b>+</b></sup> group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma: A pilot study.